Potenziell tödliche Toxizität von Fluoropyrimidinen bei der Anwendung kurz vor, gleichzeitig mit oder innerhalb von 4 Wochen nach Ende der Behandlung mit Brivudin
Restricted phone availability – please write to us instead!
Due to the COVID-19 pandemic, Swissmedic is currently receiving more queries than usual. We are therefore unable to receive telephone enquiries. Please submit your questions to us by e-mail (anfragen@swissmedic.ch).
What is a medical device? How do medical devices come onto the market? How do you recognise a medical device? Based on examples, our videos answer these and a number of other questions.
Swissmedic is the Swiss authority responsible for the authorisation and supervision of therapeutic products. Swissmedic's activities are based on the Law on Therapeutic Products.
